Shandong Jincheng Pharmaceutical Group Co., Ltd (SZSE: 300233)
Health Care · Pharmaceuticals · CN
CN¥13.77
-4.38% today · -29.8% 1Y
Shandong Jincheng Pharmaceutical Group Co., Ltd (SZSE: 300233) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $777.01M and employs 3,515 people.
Over the last twelve months the share price has lost 29.8%, trading between 11.58 and 22.47.
Tweenvest scores Shandong Jincheng Pharmaceutical Group Co., Ltd across four factors: quality 72/100, value 52/100, growth 19/100, dividend 30/100. Its strongest factor is quality.
300233 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $777.01M
- Revenue (TTM)
- $415.72M
- P/E
- 35.36
- EPS
- 0.39
- Dividend yield
- 1.82%
- Beta (5Y)
- 0.53
- 52-week high
- CN¥22.47
- 52-week low
- CN¥11.58
- Avg volume (3M)
- —
- Shares outstanding
- 379.33M
- Employees
- 3,515
- Next earnings
- —
About Shandong Jincheng Pharmaceutical Group Co., Ltd
Shandong Jincheng Pharmaceutical Group Co., Ltd., together with its affiliated companies, focuses on the global research, development, manufacturing, and distribution of Cephalosporin intermediates. The Group's extensive product line includes active pharmaceutical ingredients (APIs), biopharmaceutical products, various medical intermediates, specialty fine chemicals, and final dosage form medications. Additionally, it diversifies its operations by offering animal nutrition and healthcare products, as well as providing contract manufacturing (CMO) and contract development and manufacturing (CDMO) services. Established in 2004, the company is headquartered in Zibo, China.
- ISIN
- CNE100001500
- Founded
- 2004
- Listed since
- Jun 22, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,199.25 | -2.79% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.42 | -1.00% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $154.02 | -1.55% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.40 | -0.60% |
Figures last refreshed Aug 18, 2026.